The regulation of protective immunity to viruses by L-selectin
The regulation of protective immunity to viruses by L-selectin
批准号:
BB/S002480/1
负责人:
Ann Ager
金额:
$71.09万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Virus infections in animals and humans cause morbid and fatal diseases which incur a severe economic burden. The ability of animals and humans to combat viruses depends on a subset of white blood cells called T lymphocytes. When a virus enters the body, T lymphocytes are presented with virus extracts in local lymph glands and turned into killer T cells before they are despatched to fight the virus. Some killer T cells turn into memory T cells which remember the virus and prevent re-infection. How killer T cells find their way to virus infected tissues, such as influenza infected lungs, is not understood.Our latest work has identified a homing molecule on killer T cells, called L-selectin, that directs them to virus-infected tissues and maintains immune memory to that virus. L-selectin is lost from the surface of T lymphocytes as they turn into killer T cells. So more of it needs to be made by the killer T-cells before they leave the lymph glands, otherwise they can't sense detect infected cells in the body. By increasing the expression of L-selectin on killer T cells we can increase the number of killer T cells at the site of infection and boost killing of virus. However, if T lymphocytes do not make more L-selectin they are unable to locate where virus is growing and clear it from the bodyIn this proposal we want to find out how the level of L-selectin on the surface of killer T cells is controlled and what effect L-selectin has on memory T cells. We will also identify how L-selectin senses a virus-infected tissue by finding what binds to it to make T-lymphocytes go to the virus infected organs. There are currently no anti-viral drugs for many of the viruses that cause significant morbidity in animals and mortality in young and elderly humans. Furthermore, vaccines are either not available or need to be re-formulated every season, like with influenza. Our studies of killer T cell homing have revealed a new way of boosting the immune system. This is by increasing the homing of killer T cells to virus infected tissues. Understanding how L-selectin is involved in killer T cells will help to develop new approaches to combat viral infections in people and livestock.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/pathogens11020150
发表时间:
2022-01-25
期刊:
Pathogens (Basel, Switzerland)
影响因子:
--
作者:
[Reed SG, Ager A]
通讯作者:
Ager A
DOI:
10.1007/s00262-020-02603-x
发表时间:
2020-10
期刊:
Cancer immunology, immunotherapy : CII
影响因子:
--
作者:
[Hughes E, Lauder SN, Smart K, Bloom A, Scott J, Jones E, Somerville M, Browne M, Blainey A, Godkin A, Ager A, Gallimore A]
通讯作者:
Gallimore A
ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells.
L-选择素的 ADAM17 依赖性蛋白水解促进细胞毒性 T 细胞的早期克隆扩增。
DOI:
10.1038/s41598-019-41811-z
发表时间:
2019
期刊:
Scientific reports
影响因子:
4.6
作者:
[Mohammed RN]
通讯作者:
Mohammed RN
DOI:
10.1172/jci91512
发表时间:
2018-04-02
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
[Miles JJ, Tan MP, Dolton G, Edwards ES, Galloway SA, Laugel B, Clement M, Makinde J, Ladell K, Matthews KK, Watkins TS, Tungatt K, Wong Y, Lee HS, Clark RJ, Pentier JM, Attaf M, Lissina A, Ager A, Gallimore A, Rizkallah PJ, Gras S, Rossjohn J, Burrows SR, Cole DK, Price DA, Sewell AK]
通讯作者:
Sewell AK
Dissecting the impact of L-selectin on T lymphocyte dependent tumour immunity
-
批准号:MR/L008742/1
-
项目类别:Research Grant
-
资助金额:$55.0万
-
财政年份:2014
-
负责人:Ann Ager
-
依托单位:
国内基金
海外基金
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
-
批准号:82371317
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:万杰清
-
依托单位: